Publications
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies2021 | Faculty of Pharmacy in Hradec Králové
- Development of versatile and potent monoquaternary reactivators of acetylcholinesterase2021 | Publication without faculty affiliation
- Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile2020 | Publication without faculty affiliation
- In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain Barrier2019 | Publication without faculty affiliation
- The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease2018 | Faculty of Pharmacy in Hradec Králové
- A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase2018 | Publication without faculty affiliation
- Tacrine-coumarin and Tacrine-7-chloroquinoline Hybrids with Thiourea Linkers: Cholinesterase Inhibition Properties, Kinetic Study, Molecular Docking and Permeability Assay for Blood-brain Barrier2018 | Publication without faculty affiliation
- Novel Tacrine-Scutellarin hybrids as multipotent Anti-Alzheimer's agents: Design, synthesis and biological evaluation2017 | Publication without faculty affiliation
Loading network view...